The ways for ginsenoside Rh2 to fi ght against cancer: the molecular evidences in vitro and in vivo

Cancer is a global public health issue that becomes the second primary cause of death globally. Considering the side effects of radio- or chemo-therapy, natural phytochemicals are promising alternativesfor therapeutic interventions to alleviate the side effects and complications. Ginsenoside Rh2(GRh...

Full description

Saved in:
Bibliographic Details
Published in:Journal of ginseng research 2023, 47(2), , pp.173-182
Main Authors: Qi-rui Hu, Yao Pan, Han-cheng Wu, Zhen-zhen Dai, Qing-xin Huang, Ting Luo, Jing Li, Ze-yuan Deng, Fang Chen
Format: Article
Language:English
Subjects:
기타의약학
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer is a global public health issue that becomes the second primary cause of death globally. Considering the side effects of radio- or chemo-therapy, natural phytochemicals are promising alternativesfor therapeutic interventions to alleviate the side effects and complications. Ginsenoside Rh2(GRh2) is the main phytochemical extracted from Panax ginseng C.A. Meyer with anticancer activity. GRh2 could induce apoptosis and autophagy of cancer cells and inhibit proliferation, metastasis, invasion,and angiogenesis in vitro and in vivo. In addition, GRh2 could be used as an adjuvant to chemotherapeuticsto enhance the anticancer effect and reverse the adverse effects. Here we summarized the understandingof the molecular mechanisms underlying the anticancer effects of GRh2 and proposed futuredirections to promote the development and application of GRh2. KCI Citation Count: 0
ISSN:1226-8453
2093-4947
DOI:10.1016/j.jgr.2022.09.011